A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33980831/

doi: 10.1038/s41408-021-00478-4. 1 Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA. 2 Unité Hémopathies Lymphoïdes, CHU Henri Mondor, Créteil, France. 3 Service d'hématologie, CHRU Hôpitaux de...

tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33971811/

doi: 10.1186/s12859-021-04167-8. 1 Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, 410000, China. 2 Department of Blood Transfusion, The Seventh Affiliated Hospital of Sun Yat-Sen University,...

Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33981333/

doi: 10.3389/fgene.2021.665173. 1 Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China. 2 Department of Hematology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai,...

Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33979466/

doi: 10.1002/jmri.27637. Online ahead of print. 1 Department of Radiology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China. 2 Huiying Medical Technology (Beijing) Co., Ltd, Beijing, China....

Multiple myeloma presenting as cryoglobulinemic vasculitis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33948463/

doi: 10.1016/j.jdcr.2021.03.026. 1 Medical School, University of Michigan, Ann Arbor, Michigan. 2 Ochsner Health Center, New Orleans, Louisiana. 3 Department of Pathology, University of Michigan, Ann Arbor, Michigan. 4 Division...